文献速递临床试验与 GCP

重复低强度红光联合离焦整合多段眼镜片控制儿童近视的疗效与安全性:一项为期12个月、随机、平行对照、单中心临床试验的研究方案

The efficacy and safety of combination therapy of repeated low-level red light and defocus-incorporated multiple segments spectacle lenses for myopia control in children: the study protocol for a 12-month, randomized, parallel-controlled, and single-center clinical trial.
PubMed 文献 · Trials · 2024-07-30

本研究为一项为期12个月、随机、平行对照、单中心临床试验,计划招募66例8-12岁、睫状肌麻痹下双眼等效球镜度在-0.50 D至-6.00 D之间的中国学龄期近视儿童,按1:1随机分为干预组(重复低强度红光治疗联合离焦整合多段眼镜片)和对照组(仅离焦整合多段眼镜片),主要结局为12个月时眼轴长度变化,次要结局包括睫状肌麻痹下屈光度变化、光学相干断层扫描、多焦视网膜电图、色觉及受试者报告的不良事件。

要点

  • 拟纳入66例8-12岁、睫状肌麻痹下等效球镜度-0.50 D至-6.00 D的近视儿童,按1:1随机分组。
  • 干预组在家每周一至周五每日两次重复低强度红光治疗,每次3分钟,间隔至少4小时,日间佩戴离焦整合多段眼镜片。
  • 主要结局为12个月时眼轴长度变化,次要结局包括屈光度、光学相干断层扫描、多焦视网膜电图、色觉及不良事件。

核心结论

  • 本研究将详细报告重复低强度红光联合离焦整合多段眼镜片与单用离焦整合多段眼镜片相比,对学龄期近视儿童的疗效与安全性结局。

研究设计与样本

  • 本研究为为期12个月、随机、平行对照、单中心临床试验,计划从本院招募66例受试者,按1:1比例分配。
  • 纳入标准为8-12岁、睫状肌麻痹下双眼等效球镜度在-0.50 D至-6.00 D之间的儿童。
  • 干预组接受重复低强度红光治疗装置治疗,每周一至周五每日两次在家进行,每次3分钟,间隔至少4小时,在父母/监护人监督下;日间佩戴离焦整合多段眼镜片矫正近视。
  • 对照组不接受重复低强度红光治疗,仅佩戴离焦整合多段眼镜片矫正近视。
  • 两组受试者每6个月到医院随访一次。

关键数值与推荐

  • 主要结局为12个月时眼轴长度变化。
  • 次要结局包括12个月时睫状肌麻痹下屈光度变化、光学相干断层扫描、多焦视网膜电图、色觉及受试者报告的不良事件。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Myopia is increasing in prevalence worldwide. Combination therapy showed a better effect on myopia control than monotherapy. Repeated low-level red light therapy (RLRL) therapy and defocus-incorporated multiple segment (DIMS) spectacle lenses have been reported to retard myopia progression significantly. However, whether these two therapies are better than one is still unknown. The present study aims to report the study protocol of a trial designed to evaluate the efficacy and safety of combination therapy of RLRL and DIMS versus DIMS alone for reducing the progression of myopia among Chinese school-aged children. METHODS: This study is a 12-month, randomized, parallel-controlled, single-center clinical trial. We will recruit children aged 8-12 years with spherical equivalence (SE) between - 0.50 D and - 6.00 D under cycloplegia in both eyes. We will recruit 66 participants with an allocation ratio of 1:1 from our hospital. Participants in the intervention group will be treated with an RLRL therapy device twice a day from Monday to Friday at home, 3 min per session, with a minimum interval of 4 h, under the supervision of their parents/guardians. They will wear DIMS spectacles for myopia correction during the day. Participants in the control group will not receive the RLRL therapy and will only wear DIMS spectacles to correct myopia. Participants from both groups will attend the hospital every 6 months. The primary outcome is the change in axial length at 12 months. Secondary outcomes include changes in refraction under cycloplegia, optical coherence tomography (OCT), multifocal electroretinogram (mfERG), color vision, and participants' self-reporting of adverse events at 12 months. DISCUSSION: This study will report the efficacy and safety outcome of the combination therapy of RLRL and DIMS versus DIMS for school-aged children with myopia in detail. TRIAL REGISTRATION: ChiCTR2300075398. Registered 4 September 2023. https://www.chictr.org.cn/bin/project/edit?pid=200751 .

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Zhang H, Song D, Wei R, et al. The efficacy and safety of combination therapy of repeated low-level red light and defocus-incorporated multiple segments spectacle lenses for myopia control in children: the study protocol for a 12-month, randomized, parallel-controlled, and single-center clinical trial. Trials. 2024. PMID: 39080704. doi:10.1186/s13063-024-08210-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。